representatives of the medical and pharmaceutical professions and of the Department of Health. The Committee uses for its principal source of information the views of expert advisers, who are also practising clinicians. The Committee also uses sources such as government publications (for example, on vaccine guidelines) and CSM warnings (which are highlighted). While monographs in the BNF generally reflect the statements made in manufacturers' Data Sheets, the view of the BNF, as an independent publication, sometimes differs: such differences are always made clear to the reader.
The BNF provides information about all drugs available on the UK market. In former incarnations, Mrs Prasad explained, the BNF had been selective but a need had been detected for a more comprehensive publication, incorporating a much wider range of drugs while still providing informed comment. In particular, it is considered educational to retain a drug and criticize it rather than merely
Fish and olives
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In terms of dietary advice, in relation to cardiovascular diseases, the main emphasis during the last two decades has been on decreasing the total amount of fat in the diet, particularly those fats containing saturated fatty acids, while increasing the proportion of polyunsaturated fatty acids (increasing the PIS ratio). The term polyunsaturated referred mainly to essential fatty acids of the n-6 series, particularly linoleic acid. In recent years evidence has come to light which suggests that other types of fatty acids may be beneficial. Monounsaturated fatty such as oleic acid, the principal fatty acid of olive and other plant oils and some animal fats, have received attention recently. So too have the polyunsaturated fatty acids of the n-3 series which are found in some plant oils (eg a-linolenic acid), but also longer chain fatty acids found in fish oils which have five or six unsaturated bonds such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The aim of the meeting was to review the evidence for the effects of these fatty acids, consider possible mechanisms of action and, if possible, to make dietary recommendations.
The meeting began with an excellent presentation by Professor S Grundy (Dallas) who showed that substitution of monounsaturated for saturated fatty acids lowered total serum cholesterol levels and those of low-density lipoprotein (LDL) cholesterol to the same extent as the polyunsaturates. Furthermore, polyunsaturated fatty acids have some potential disadvantages which monounsaturates do not have: (1) they lower serum high density lipoprotein (HDL) cholesterol (high HDL levels are considered to be beneficial), (2) there may be an increased risk of gallstones, (3) some animal experiments indicate that polyunsaturated fatty acids may predispose to cancer to delete it. Mrs Prasad believed that the BNF could be used as a reference for the development of other formularies. It is authoritative, uses a practical classification system (which is also used by the Prescription Pricing Authority) and is up-to-date. In general, the BNF does not aim to provide treatment guidelines -it is primarily a book about drugs.
Summing up the day's proceedings, the Forum's chairman Dr John Mucklow identified three aspects needing further consideration. There is a need, first, to measure the benefit of formularies in terms of clinical outcome; second, to ascertain whether it is better to operate a formulary on a compulsory or voluntary basis; and third, to encourage the wider adoption of prescribing policies without making them too uniform across the country. Variation is important, he concluded, particularly if the development of new drugs is not to be discouraged.
S Chaplin Drug Information Specialist if taken in excess, (4) there is a greater risk of autoxidation, (5)there is some evidence that excessive polyunsaturate intake may lead to suppression of the immune system. There is no epidemiological basis for a dietary level of polyunsaturates greater than 10% of total energy intake. The diets of Mediterranean countries are rich in monounsaturated fatty acids and are associated with a lower risk of cardiovascular disease (CVD). This supports the proposition that monounsaturated fatty acids should form a major part of the dietary fat intake.
Professor Grundy also introduced evidence that not all saturated fatty acids are identical in their effects on serum cholesterol levels, a forgotten observation of Ahrens more than 20 years ago. Stearic acid (lSC long) has similar effects to oleic acid, whereas palmitic (16C)and myristic (14C)acids raise serum cholesterol in human subjects. This may be due to the fact that stearic acid is readily desaturated to oleic acid in the body. A possible mechanism for the action of the shorter chain saturated fatty acids is that they reduce the expression of receptors for LDL in the liver and thereby decrease the clearance of LDL cholesterol from the circulation. The question whether the trans forms of monounsaturated fatty acids, which appear in fats which have been manufactured by hydrogenation of oils, have any harmful effects on serum cholesterol levels has not been resolved. In the subsequent discussion Dr H Sinclair (Oxford) pointed out that stearic acid increases thrombotic tendencies. Professor Grundy said that he did not advocate an increase in stearic acid in the diet.
Professor M Crawford (London) opened a discussion about the different kinds of polyunsaturated fatty acids and their uses and highlighted the importance of the n-6 and n-3 series in membrane structure, especially the n-3 in nervous tissue. He suggested that monounsaturated fatty acids had a sparing action on n-3 and n-6 polyunsaturates by reducing the extent of their mitochondrial oxidation. Dr T Saunders (London) continued the theme of the comparison of the n-3 and n-6 polyunsaturated fatty acids and showed that the effects oflinoleic acid in lowering serum HDL cholesterol did not occur until the polyunsaturated fatty acids formed 12% of total energy intake. Linoleic acid also decreased the synthesis of EPA and DHA from a-linolenic acid, a phenomenon observable in vegans. EPA and DHA markedly reduce serum very low density lipoproteins (VLDL) which are triglyceride rich (in contrast to alinolenic acid which does not), but have little effect on cholesterol levels. Modest intakes of fish oils increase the serum HDL 2 fraction whereas high intakes will lower total HDL. There are some other possible disavantages in a high dietary intake offish oils: (1) impaired glucose homeostasis; (2) increased requirement of anti-oxidants and risk of yellow fat disease (steatitis); (3) may exacerbate asthma in aspirin-sensitive patients; (4) may increase the incidence of haemorrhagic stroke. One study had shown increased monocyte counts and decreased serum vitamin E levels after high doses of fish oils. Dr Sanders recommended a diet where 35% or less of the total energy intake was from fat, of which 8-10% should be from polyunsaturated fatty acids (including the n-3 fatty acids), 10% from saturated fat and the rest made up from monounsaturates.
Professor F E Preston (Sheffield) focused his remarks on the reported anti-thrombotic properties of fish oils and their effects on platelet activity. Greenland eskimos appear to have minor bleeding disorders such as prolonged bleeding time and prolonged nosebleeds, but also a high incidence of haemorrhagic stroke, which have given rise to theories that EPA and DHA are incorporated into the platelet membrane and this leads to a decrease in the release of thromboxane A 2 and the formation of the biologically inactive TXA 3 · Feeding volunteers with Maxepa capsules (fish oil concentrates) showed little incorporation of EPA into the important membrane phospholipid phosphatidylinositol and no abnormality of platelet function. He proposed that the effect of EPA is on the rheological properties of the blood by decreasing whole blood viscosity and increasing red cell deformability. Erythrocytes do influence bleeding time and the adhesion of platelets to sub-endothelial components. Dr Wable (Aberdeen) said that there were effects on platelet activity using whole blood aggregometry if vitamin E supplements were given with the fish oil.
Professor D Kromhout (Bilthoven, The Netherlands) discussed the epidemiological evidence for the importance of fish consumption in relation to cardiovascular disease. A number of studies, including his own Zutphen study, have shown an inverse correlation between the consumption of fish and cardiovascular disease, although there are notable exceptions to this, particularly a Norwegian study. In the longstanding Seven Countries Study, there was also an inverse correlation. However, in eastern Finland there was a high fish consumption and a high mortality from CVD, which was attributed to high intake of saturated fats. In the Zutphen study there seemed to be little advantage in a large consumption of fish, modest consumption having the greatest effect.
It is important to distinguish between oily fish consumption and that of less oily fish (lowoil in muscle Journal of the Royal Society of Medicine Volume 83 March 1990 195 compared to liver, eg cod). It is worth noting that eskimos have much lower VLDL concentrations than their Danish comparators and this was noted among the fish eaters of Zutphen.
Dr D A Wood (Southampton) described a number of clinical trials related to increased intake of polyunsaturated fats. The results ofboth primary and secondary prevention trials have been disappointing which may indicate the intervention had been too little, too late, for too short a time and often with too little statistical power. Dr M Burr was asked to make a short contribution at this point to explain the results he has recently published in the Lancet where he studied 2000 non-diabetics with myocardial infarction. The patients were given types of dietary advice, eg low fat or high fibre or high fish intake (sometimes with Maxepa supplement to aid compliance). A significant reduction in deaths from ischaemic heart disease was observed after 2 years only in the group advised to eat more fish. Professor M Oliver (Edinburgh) pointed out that the key event at this stage was thrombosis and this should be the subject of the intervention.
Professor M I Gurr (Thames Ditton) considered the possible harmful effects of unsaturated fatty acids. There are few naturally occurring fatty acids that are intrinsically toxic. Sterculic acid (cotton seed oil and some fish) and erucic acid (rape seed oil) are examples, although few known instances of actual deleterious effects can be shown in man. Trans fatty acids occur naturally in plants and ruminant products as well as by chemical processing of oils, but no specific toxic effects are known. Peroxidation of polyunsaturated fats may be a problem when used repeatedly for cooking, but lipid hydroperoxides are poorly absorbed from the gut. The presence of anti-oxidants and losses in cooking may be important here. He reiterated the possible problem of immunosuppression with high polyunsaturate intakes which was demonstrable with skin grafting. Therefore, dietary recommendations should avoid any excess and obviate any potential harmful effects of unsaturated fatty acids.
Professor Oliver concluded the meeting with a presentation of evidence that low amounts of linoleic acid in adipose tissue or platelet lipids were independently correlated with a high incidence of CVD, so that populations with high risk, such as in Scotland or East Finland, had low concentrations of linoleate. Smokers had low amounts of linoleic acid and EPA and seemed to have a low dietary intake of these fatty acids: this was unrelated to social class. The anti-oxidant status is also important, new patients with angina having low plasma ascorbate and cholesterol-standardized a-tocopherol concentrations. In France smokers are recommended to increase their ascorbate intake.
Professor Oliver believed that the dietary recommendations of the COMA report, namely a reduction in total fat and an increase in the PIS ratio, were still valid. They can be expanded to include the monounsaturates and fish oils as suggested by Dr Saunders.
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